An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4.
Clinical trial NCT00002194 · COMPLETED
Trial details
- NCT number
- NCT00002194
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.